{"id":"https://openalex.org/W2781007106","doi":"https://doi.org/10.1158/1535-7163.mct-17-0605","title":"\u03b2-Catenin mRNA Silencing and MEK Inhibition Display Synergistic Efficacy in Preclinical Tumor Models","display_name":"\u03b2-Catenin mRNA Silencing and MEK Inhibition Display Synergistic Efficacy in Preclinical Tumor Models","publication_year":2017,"publication_date":"2017-12-27","ids":{"openalex":"https://openalex.org/W2781007106","doi":"https://doi.org/10.1158/1535-7163.mct-17-0605","mag":"2781007106","pmid":"https://pubmed.ncbi.nlm.nih.gov/29282298","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5805618"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-17-0605","doi":"https://doi.org/10.1158/1535-7163.mct-17-0605","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-17-0605","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://europepmc.org/pmc/articles/PMC5805618","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085330447","display_name":"Shanthi Ganesh","orcid":"https://orcid.org/0000-0001-9278-0865","observed_orcids":["https://orcid.org/0000-0001-9278-0865"]},"institutions":[{"id":"https://openalex.org/I4210143007","display_name":"Dicerna Pharmaceuticals (United States)","ror":"https://ror.org/03qcf9t82","country_code":"US","type":"company","lineage":["https://openalex.org/I4210143007"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Shanthi Ganesh","raw_affiliation_strings":["Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210143007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068167167","display_name":"Xue Shui","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143007","display_name":"Dicerna Pharmaceuticals (United States)","ror":"https://ror.org/03qcf9t82","country_code":"US","type":"company","lineage":["https://openalex.org/I4210143007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xue Shui","raw_affiliation_strings":["Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210143007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043853532","display_name":"Kevin P. Craig","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143007","display_name":"Dicerna Pharmaceuticals (United States)","ror":"https://ror.org/03qcf9t82","country_code":"US","type":"company","lineage":["https://openalex.org/I4210143007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin P. Craig","raw_affiliation_strings":["Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210143007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010028748","display_name":"Martin L. Koser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143007","display_name":"Dicerna Pharmaceuticals (United States)","ror":"https://ror.org/03qcf9t82","country_code":"US","type":"company","lineage":["https://openalex.org/I4210143007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martin L. Koser","raw_affiliation_strings":["Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210143007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066504409","display_name":"Girish Rajmal Chopda","orcid":"https://orcid.org/0009-0003-7022-2637","observed_orcids":["https://orcid.org/0009-0003-7022-2637"]},"institutions":[{"id":"https://openalex.org/I4210143007","display_name":"Dicerna Pharmaceuticals (United States)","ror":"https://ror.org/03qcf9t82","country_code":"US","type":"company","lineage":["https://openalex.org/I4210143007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Girish R. Chopda","raw_affiliation_strings":["Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210143007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054706156","display_name":"Wendy A. Cyr","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143007","display_name":"Dicerna Pharmaceuticals (United States)","ror":"https://ror.org/03qcf9t82","country_code":"US","type":"company","lineage":["https://openalex.org/I4210143007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wendy A. Cyr","raw_affiliation_strings":["Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210143007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018703558","display_name":"Cheng-Jung Lai","orcid":"https://orcid.org/0000-0002-3321-8984","observed_orcids":["https://orcid.org/0000-0002-3321-8984"]},"institutions":[{"id":"https://openalex.org/I4210143007","display_name":"Dicerna Pharmaceuticals (United States)","ror":"https://ror.org/03qcf9t82","country_code":"US","type":"company","lineage":["https://openalex.org/I4210143007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chengjung Lai","raw_affiliation_strings":["Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210143007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110068812","display_name":"Henryk Dudek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143007","display_name":"Dicerna Pharmaceuticals (United States)","ror":"https://ror.org/03qcf9t82","country_code":"US","type":"company","lineage":["https://openalex.org/I4210143007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Henryk Dudek","raw_affiliation_strings":["Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210143007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100331948","display_name":"Weimin Wang","orcid":"https://orcid.org/0000-0002-4531-835X","observed_orcids":["https://orcid.org/0000-0002-4531-835X"]},"institutions":[{"id":"https://openalex.org/I4210143007","display_name":"Dicerna Pharmaceuticals (United States)","ror":"https://ror.org/03qcf9t82","country_code":"US","type":"company","lineage":["https://openalex.org/I4210143007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Weimin Wang","raw_affiliation_strings":["Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210143007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103975901","display_name":"Bob D. Brown","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143007","display_name":"Dicerna Pharmaceuticals (United States)","ror":"https://ror.org/03qcf9t82","country_code":"US","type":"company","lineage":["https://openalex.org/I4210143007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bob D. Brown","raw_affiliation_strings":["Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210143007"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029964675","display_name":"Marc T. Abrams","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143007","display_name":"Dicerna Pharmaceuticals (United States)","ror":"https://ror.org/03qcf9t82","country_code":"US","type":"company","lineage":["https://openalex.org/I4210143007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marc T. Abrams","raw_affiliation_strings":["Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dicerna Pharmaceuticals, Inc, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I4210143007"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5085330447"],"corresponding_institution_ids":["https://openalex.org/I4210143007"],"apc_list":null,"apc_paid":null,"fwci":1.3632,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.78994484,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"17","issue":"2","first_page":"544","last_page":"553"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10929","display_name":"Wnt/\u03b2-catenin signaling in development and cancer","score":0.7681000232696533,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10929","display_name":"Wnt/\u03b2-catenin signaling in development and cancer","score":0.7681000232696533,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.13830000162124634,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.05119999870657921,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mek-inhibition","display_name":"MEK inhibition","score":0.8159999847412109},{"id":"https://openalex.org/keywords/trametinib","display_name":"trametinib","score":0.9929999709129333},{"id":"https://openalex.org/keywords/rna-interference","display_name":"RNA interference","score":0.460999995470047},{"id":"https://openalex.org/keywords/wnt-beta-catenin-signaling","display_name":"Wnt/\u03b2-catenin signaling","score":0.8690000176429749},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.996999979019165},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7549999952316284},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.8399999737739563},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8569999933242798},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":1.0},{"id":"https://openalex.org/keywords/colorectal-liver-metastases","display_name":"colorectal liver metastases","score":0.9100000262260437},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.875}],"concepts":[{"id":"https://openalex.org/C2778472372","wikidata":"https://www.wikidata.org/wiki/Q7833138","display_name":"Trametinib","level":4,"score":0.835274875164032},{"id":"https://openalex.org/C137620995","wikidata":"https://www.wikidata.org/wiki/Q155769","display_name":"Wnt signaling pathway","level":3,"score":0.7790312170982361},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.6696450710296631},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6538550853729248},{"id":"https://openalex.org/C30145163","wikidata":"https://www.wikidata.org/wiki/Q384104","display_name":"Catenin","level":4,"score":0.6180893182754517},{"id":"https://openalex.org/C119056186","wikidata":"https://www.wikidata.org/wiki/Q1431332","display_name":"Gene silencing","level":3,"score":0.6154966354370117},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.5955343246459961},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5327838659286499},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.5069275498390198},{"id":"https://openalex.org/C166703698","wikidata":"https://www.wikidata.org/wiki/Q201993","display_name":"RNA interference","level":4,"score":0.5008342266082764},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4816531240940094},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4774218797683716},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.464219331741333},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34062570333480835},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2896863520145416},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.24592745304107666},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.21425825357437134},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17205023765563965},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.0755089819431305},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.07496607303619385},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.06115847826004028},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008114","descriptor_name":"Liver Neoplasms, Experimental","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011744","descriptor_name":"Pyrimidinones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D020868","descriptor_name":"Gene Silencing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020930","descriptor_name":"MAP Kinase Kinase Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D020930","descriptor_name":"MAP Kinase Kinase Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020935","descriptor_name":"MAP Kinase Signaling System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D034741","descriptor_name":"RNA, Small Interfering","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D034741","descriptor_name":"RNA, Small Interfering","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051176","descriptor_name":"beta Catenin","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D051176","descriptor_name":"beta Catenin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D060449","descriptor_name":"Wnt Signaling Pathway","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D064593","descriptor_name":"Heterografts","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1158/1535-7163.mct-17-0605","doi":"https://doi.org/10.1158/1535-7163.mct-17-0605","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-17-0605","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:29282298","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29282298","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:5020207","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC5805618","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5805618","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5805618/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Mol Cancer Ther","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:5020207","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC5805618","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2355954828","display_name":"Optimization of a clinical stage nanoparticle drug delivery platform","funder_award_id":"R43CA186410","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3731830588","display_name":"Optimization of a clinical stage nanoparticle drug delivery platform","funder_award_id":"R44CA186410","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4548428633","display_name":null,"funder_award_id":"IR43CA186410-01A1 and IR43CA186410-02","funder_id":"https://openalex.org/F4320310678","funder_display_name":"Center for Strategic Scientific Initiatives, National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320310678","display_name":"Center for Strategic Scientific Initiatives, National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":74,"referenced_works":["https://openalex.org/W203927818","https://openalex.org/W1498931318","https://openalex.org/W1532573130","https://openalex.org/W1655178001","https://openalex.org/W1856892620","https://openalex.org/W1857766814","https://openalex.org/W1957080627","https://openalex.org/W1972070251","https://openalex.org/W1991401350","https://openalex.org/W1992372073","https://openalex.org/W1993239788","https://openalex.org/W1994928797","https://openalex.org/W2005139996","https://openalex.org/W2011123905","https://openalex.org/W2014881369","https://openalex.org/W2027065383","https://openalex.org/W2031134972","https://openalex.org/W2032578973","https://openalex.org/W2034581192","https://openalex.org/W2036928635","https://openalex.org/W2050573392","https://openalex.org/W2052781279","https://openalex.org/W2070746836","https://openalex.org/W2075657558","https://openalex.org/W2083144753","https://openalex.org/W2084490630","https://openalex.org/W2085633477","https://openalex.org/W2086320165","https://openalex.org/W2103627259","https://openalex.org/W2103789431","https://openalex.org/W2104877706","https://openalex.org/W2105477229","https://openalex.org/W2112140640","https://openalex.org/W2114142749","https://openalex.org/W2118474093","https://openalex.org/W2131059542","https://openalex.org/W2131266547","https://openalex.org/W2135129362","https://openalex.org/W2135707008","https://openalex.org/W2136183527","https://openalex.org/W2137644376","https://openalex.org/W2143574474","https://openalex.org/W2149896139","https://openalex.org/W2150625137","https://openalex.org/W2155311724","https://openalex.org/W2157873170","https://openalex.org/W2158289038","https://openalex.org/W2165132869","https://openalex.org/W2165575701","https://openalex.org/W2168244837","https://openalex.org/W2171621406","https://openalex.org/W2211890826","https://openalex.org/W2272802268","https://openalex.org/W2307696205","https://openalex.org/W2318839442","https://openalex.org/W2330328526","https://openalex.org/W2335854816","https://openalex.org/W2341252677","https://openalex.org/W2344214299","https://openalex.org/W2401574182","https://openalex.org/W2468296498","https://openalex.org/W2491081100","https://openalex.org/W2502048764","https://openalex.org/W2506489222","https://openalex.org/W2513903220","https://openalex.org/W2531015819","https://openalex.org/W2564751880","https://openalex.org/W2568306867","https://openalex.org/W2578611388","https://openalex.org/W2587978856","https://openalex.org/W2591540920","https://openalex.org/W2599487961","https://openalex.org/W2606350123","https://openalex.org/W4211147392"],"related_works":["https://openalex.org/W2741835552","https://openalex.org/W2171621406","https://openalex.org/W2495019162","https://openalex.org/W2932225899","https://openalex.org/W2526793520","https://openalex.org/W2011123905","https://openalex.org/W2890917067","https://openalex.org/W2329429650","https://openalex.org/W2468296498","https://openalex.org/W2619343782"],"abstract_inverted_index":{"Abstract":[0],"Colorectal":[1],"carcinomas":[2],"harbor":[3],"well-defined":[4],"genetic":[5],"abnormalities,":[6],"including":[7,28],"aberrant":[8],"activation":[9],"of":[10,46,67,70,106,144,155,182],"Wnt/\u03b2-catenin":[11,189],"and":[12,30,49,110,132,190],"MAPK":[13,19,191],"pathways,":[14],"often":[15],"simultaneously.":[16],"Although":[17],"the":[18,44,90],"pathway":[20,192],"can":[21],"be":[22],"targeted":[23],"using":[24],"potent":[25],"small-molecule":[26],"drugs,":[27],"BRAF":[29],"MEK":[31,92],"inhibitors,":[32],"\u03b2-catenin":[33,156],"inhibition":[34,101],"has":[35],"been":[36],"historically":[37],"challenging.":[38],"RNAi":[39,85],"approaches":[40],"have":[41],"advanced":[42],"to":[43,119,171],"stage":[45],"clinical":[47,180],"viability":[48],"are":[50,163],"especially":[51],"well":[52],"suited":[53],"for":[54,179,186],"transcriptional":[55],"modulators,":[56],"such":[57],"as":[58,124],"\u03b2-catenin.":[59],"In":[60,151],"this":[61,183],"study,":[62],"we":[63,96],"report":[64],"therapeutic":[65],"effects":[66],"combined":[68],"targeting":[69],"these":[71],"pathways":[72],"with":[73,89],"pharmacologic":[74,153],"agents.":[75],"Using":[76],"a":[77,83,176],"recently":[78],"described":[79],"tumor-selective":[80],"nanoparticle":[81],"containing":[82],"\u03b2-catenin\u2013targeting":[84],"trigger,":[86],"in":[87,102,103,129],"combination":[88,126],"FDA-approved":[91],"inhibitor":[93],"(MEKi)":[94],"trametinib,":[95],"demonstrate":[97],"synergistic":[98,130],"tumor":[99,122,134],"growth":[100,123,135],"vivo":[104],"models":[105],"colorectal":[107,147],"cancer,":[108],"melanoma,":[109],"hepatocellular":[111],"carcinoma.":[112],"At":[113],"dose":[114],"levels":[115],"that":[116,162,167],"were":[117],"insufficient":[118],"significantly":[120],"impact":[121],"monotherapies,":[125],"regimens":[127],"resulted":[128],"efficacy":[131],"complete":[133],"inhibition.":[136],"Importantly,":[137],"dual":[138],"MEKi/RNAi":[139],"therapy":[140],"dramatically":[141],"improved":[142],"survival":[143],"mice":[145],"bearing":[146],"cancer":[148],"liver":[149],"metastases.":[150],"addition,":[152],"silencing":[154],"mRNA":[157],"was":[158],"effective":[159],"against":[160],"tumors":[161],"inherently":[164],"resistant":[165],"or":[166],"acquire":[168],"drug-induced":[169],"resistance":[170],"trametinib.":[172],"These":[173],"results":[174],"provide":[175],"strong":[177],"rationale":[178],"evaluation":[181],"dual-targeting":[184],"approach":[185],"cancers":[187],"harboring":[188],"mutations.":[193],"Mol":[194],"Cancer":[195],"Ther;":[196],"17(2);":[197],"544\u201353.":[198],"\u00a92017":[199],"AACR.":[200]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":4}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2018-01-05T00:00:00"}